Medicinova Inc (MNOV)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4275 EXECUTIVE SQUARE LA JOLLA, CA 92037

MediciNova Inc. a biopharmaceutical company engages in the acquisition and development of small molecule therapeutics worldwide.

Data as of 2021-05-08 10:42:09 -0400
Market Cap199.951 Million Shares Outstanding48.769 Million Avg 30-day Volume355.742 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-10.51 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.96954 52-week High/Low13.25 / 3.9 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from MNOV instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 57 53 7.55% 12 (0.72%) 14 (0.87%) -14.29%
13F shares: 10.989 Million 9.724 Million 13.0% 2.506 Million 2.443 Million 2.6%
% Ownership 24.4583 21.6445 13.0% 5.578 5.4367 2.6%
New Positions: 12 8 50.0% 3 4 -25.0%
Increased Positions 20 12 66.67% 2 4 -50.0%
Closed Positions 8 6 33.33% 5 3 66.67%
Reduced Positions 14 19 -26.32% 5 4 25.0%
Total Calls 79.193 Thousand 12.74 Thousand 521.61% 19.2 Thousand 11.9 Thousand 61.34%
Total Puts 44.102 Thousand 106.501 Thousand -58.59% 0 40.8 Thousand -100.0%
PUT/CALL Ratio 0.56 8.36 -93.3% 0.0 3.43 -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MNOV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MNOV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GAETA FEDERICO C.A. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-04-22 2

NAGAO HIDEKI

  • Director
12,646 2021-03-11 4

IWAKI YUICHI PRESIDENT AND CEO

  • Officer
  • Director
1,052,350 2021-02-25 2

MATSUDA KAZUKO CHIEF MEDICAL OFFICER

  • Officer
  • Director
0 2021-02-02 2

OBRIEN GEOFFREY VICE PRESIDENT

  • Officer
0 2021-02-02 1

3D INVESTMENT PARTNERS PTE. LTD.

3D OPPORTUNITY MASTER FUND

  • 10% Owner
5,502,047 2021-01-11 1

BEAVER CAROLYN

  • Director
0 2020-10-20 2

STEPANOW EDWARD C JR. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-06-19 1

KOBAYASHI YUTAKA

  • Director
0 2020-06-16 1

ISHIZAKA YOSHIO

  • Director
0 2019-06-10 0

OKAJIMA MASATSUNE VP AND HEAD OF JAPANESE OFFICE

  • Officer
1,040,530 2019-02-28 0

REYES CARLA CHIEF FINANCIAL OFFICER

  • Officer
0 2018-06-01 0

SELHORN RYAN J CHIEF FINANCIAL OFFICER

  • Officer
0 2016-03-31 0

VAN DEN BOOM ESTHER CHIEF FINANCIAL OFFICER

  • Officer
0 2014-08-07 0

IZUMI TATSUO

  • Director
758,730 2013-12-12 0

MORRIS ARLENE

  • Director
0 2013-05-21 0

JOHNSON KIRK WILLIAM CHIEF SCIENTIFIC OFFICER

  • Officer
0 2013-05-13 0

COFFEE MICHAEL DENIS CHIEF BUSINESS OFFICER

  • Officer
0 2013-05-13 0

SATOMI HAJIME

  • 10% Owner
1,467,000 2013-05-13 0

O'TOOLE DAVID D

  • Director
5,000 2012-05-29 0

SHIGETA HIROAKI

  • Director
45,000 2012-05-10 0

NAKATA KOUSUKE

  • Director
800,000 2011-11-29 0

KISSEI PHARMACEUTICAL CO., LTD.

  • 10% Owner
800,000 2011-10-13 0

GENNARO MICHAEL J CHIEF FINANCIAL OFFICER

  • Officer
0 2011-09-01 0

PRENDERGAST JOHN K A

  • Director
0 2011-07-18 0

HIMAWAN JEFF

  • Director
0 2011-06-14 0

DUNTON ALAN W

  • Director
0 2010-06-11 0

ASAKO SHINTARO CHIEF FINANCIAL OFFICER

  • Officer
0 2010-01-29 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
0 2009-12-18 0

KALAFER MICHAEL E CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2009-07-28 0

GAMMANS RICHARD E SR CHIEF DEVELOPMENT OFFICER

  • Officer
0 2009-01-30 0

VAPNEK DANIEL

  • Director
0 2008-06-09 0

LOCKE KENNETH W CHIEF SCIENTIFIC OFFICER

  • Officer
0 2008-01-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GAETA FEDERICO C.A. - Officer CHIEF SCIENTIFIC OFFICER

2021-04-26 20:25:16 -0400 2021-04-22 A 24,000 a 24,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MEDICINOVA INC MNOV 2021-05-14 22:15:03 UTC -1.6458 1.6958 10000
MEDICINOVA INC MNOV 2021-05-14 21:45:03 UTC -1.6458 1.6958 10000
MEDICINOVA INC MNOV 2021-05-14 21:15:03 UTC -1.6458 1.6958 10000
MEDICINOVA INC MNOV 2021-05-14 20:45:03 UTC -1.8093 1.8593 10000
MEDICINOVA INC MNOV 2021-05-14 20:15:04 UTC -1.8093 1.8593 10000
MEDICINOVA INC MNOV 2021-05-14 19:45:02 UTC -1.8093 1.8593 10000
MEDICINOVA INC MNOV 2021-05-14 19:15:03 UTC -1.8093 1.8593 10000
MEDICINOVA INC MNOV 2021-05-14 18:45:03 UTC -1.8418 1.8918 10000
MEDICINOVA INC MNOV 2021-05-14 18:15:03 UTC -1.8418 1.8918 10000
MEDICINOVA INC MNOV 2021-05-14 17:45:03 UTC -1.8418 1.8918 10000
MEDICINOVA INC MNOV 2021-05-14 17:15:03 UTC -1.8418 1.8918 10000
MEDICINOVA INC MNOV 2021-05-14 16:45:03 UTC -1.5035 1.5535 10000
MEDICINOVA INC MNOV 2021-05-14 16:15:03 UTC -1.5035 1.5535 10000
MEDICINOVA INC MNOV 2021-05-14 15:45:03 UTC -1.5035 1.5535 10000
MEDICINOVA INC MNOV 2021-05-14 15:15:02 UTC -1.5035 1.5535 10000
MEDICINOVA INC MNOV 2021-05-14 14:45:04 UTC -1.5088 1.5588 10000
MEDICINOVA INC MNOV 2021-05-14 14:15:03 UTC -1.5088 1.5588 10000
MEDICINOVA INC MNOV 2021-05-14 13:45:03 UTC -1.5088 1.5588 10000
MEDICINOVA INC MNOV 2021-05-14 13:15:03 UTC -1.5088 1.5588 10000
MEDICINOVA INC MNOV 2021-05-14 12:45:03 UTC -1.5088 1.5588 2000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund MNOV -16125.0 shares, $-90138.75 2020-10-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund MNOV -3604.0 shares, $-18957.04 2020-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund MNOV -100.0 shares, $-505.0 2021-03-31 N-PORT

Elevate your investments